Abstract: Background: Bronchial asthma is known to be one of the major causes of morbidity and mortality in India. There is paucity of Indian data which evaluate the pattern of drug utilization in bronchial asthma over its entire spectrum and varying severity. Material and Methods: This is a Prospective, observational, non-interventional study of children who presented between February 2020 and November 2020. Study conducted at Department of Paediatric and Pharmacology. With a sample size of 90 patients who confirmed to the following predetermined inclusion and exclusion criteria. Result: The overall utilization of Anti-asthmatic drugs among paediatric asthma patients were found to be –short acting β2 Agonists (41.1%) long acting β2agonist (LABA) (10.0%), steroids (13.3%) and leukotriene modifiers (1.11%). Pattern of drug prescription in asthmatics showed the highest prevalence of β2 Agonists followed by corticosteroids and finally, the leukotriene modifiers. One additional antiasthmatic drug: anticholinergics were also used among patients. Conclusion: To conclude, this study provides few insights into the drug use patterns in a pediatric outpatient department of a tertiary care teaching hospital. The prescribing from NLEM was fair, the use of injections was low and there is a scope for improvement in case of medicines prescribed by generic name.